SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-013546
Filing Date
2021-12-28
Accepted
2021-12-28 16:16:16
Documents
16
Period of Report
2021-12-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT edsa_8k.htm   iXBRL 8-K 24801
2 PRESS RELEASE edsa_ex991.htm EX-99.1 95914
3 IMAGE edsa_ex991img1.jpg GRAPHIC 3303
  Complete submission text file 0001654954-21-013546.txt   251433

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA edsa-20211228.xsd EX-101.SCH 5595
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20211228_cal.xml EX-101.CAL 890
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20211228_def.xml EX-101.DEF 2097
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20211228_lab.xml EX-101.LAB 13612
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20211228_pre.xml EX-101.PRE 8627
10 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3315
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 211525146
SIC: 2834 Pharmaceutical Preparations